Considerations for use of Ebola vaccine during an emergency response. Issue 48 (15th November 2019)

• Record Type: Journal Article
• Authors: Bennett, Sarah D.; Carter, Rosalind J.; Redd, John T.; Marston, Barbara J.; Walldorf, Jenny A.; Cloessner, Emily A.; Hyde, Terri B.; MacNeil, Adam
• Is Part Of: Vaccine. Volume 37:Issue 48(2019)
• Page Start: 7190
• Page End: 7200
• Publication Date: 2019-11-15
• Subjects: Ebola infection -- Ebola virus vaccines -- Emergencies -- Outbreaks -- Strategic planning -- Vaccination; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2017.08.058
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: Vaccination against Ebola virus disease is a tool that may limit disease transmission and deaths in future outbreaks, integrated within traditional Ebola outbreak prevention and control measures. Although a licensed Ebolavirus vaccine (EV) is not yet available, the 2014–2016 West African Ebola outbreak has accelerated EV clinical trials and given public health authorities in Guinea, Liberia, and Sierra Leone experience with implementation of emergency ring vaccination. As evidence supporting the use of EV during an outbreak response has become available, public health authorities in at-risk countries are considering how to integrate EV into future emergency Ebola responses and for prevention in high-risk groups, such as healthcare workers and frontline workers (HCW/FLWs), even before an EV is licensed. This review provides an overview of Ebola epidemiology, immunology, and evidence to inform regional and country-level decisions regarding EV delivery during an emergency response and to at-risk populations before a licensed vaccine is available and beyond. Countries or regions planning to use EV will need to assess factors such as the likelihood of a future Ebolavirus outbreak, the most likely species to cause an outbreak, the availability of a safe and effective EV (unlicensed or licensed) for the affected population, capacity to implement Ebola vaccination in conjunction with standard Ebola outbreak control measures, and availability of minimum essential resources and regulatory requirements to implement emergency Ebola vaccination. Potential emergency vaccination strategies for consideration include ring or geographically targeted community vaccination, HCW/FLW vaccination, and mass vaccination. The development of guidelines and protocols for Ebola vaccination will help ensure that activities are standardized, evidence-based, and well-coordinated with overall Ebola outbreak response efforts in the future.